Dicerna Pharmaceuticals, Inc. EBITDA 2013-2021 | DRNA

Dicerna Pharmaceuticals, Inc. ebitda from 2013 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Dicerna Pharmaceuticals, Inc. Annual EBITDA
(Millions of US $)
2020 $-111
2019 $-130
2018 $-91
2017 $-60
2016 $-59
2015 $-62
2014 $-44
2013 $-17
2012 $-8
2011 $-7
Dicerna Pharmaceuticals, Inc. Quarterly EBITDA
(Millions of US $)
2021-09-30 $-17
2021-06-30 $-37
2021-03-31 $-28
2020-12-31 $-31
2020-09-30 $-22
2020-06-30 $-33
2020-03-31 $-25
2019-12-31 $-41
2019-09-30 $-33
2019-06-30 $-27
2019-03-31 $-29
2018-12-31 $-20
2018-09-30 $-19
2018-06-30 $-36
2018-03-31 $-16
2017-12-31 $-17
2017-09-30 $-15
2017-06-30 $-15
2017-03-31 $-14
2016-12-31 $-14
2016-09-30 $-14
2016-06-30 $-15
2016-03-31 $-16
2015-12-31 $-15
2015-09-30 $-17
2015-06-30 $-16
2015-03-31 $-14
2014-12-31 $-14
2014-09-30 $-11
2014-06-30 $-11
2014-03-31 $-8
2013-12-31 $-6
2013-09-30 $-4
2013-06-30 $-3
2013-03-31 $-3
2012-09-30